Literature DB >> 24510535

Interleukin-31: a novel diagnostic marker of allergic diseases.

Anja Rabenhorst1, Karin Hartmann.   

Abstract

Interleukin-31 (IL-31) is a newly discovered cytokine associated with chronic skin inflammation and pruritus. Patients with atopic dermatitis, chronic spontaneous urticaria, allergic contact dermatitis, prurigo nodularis, primary cutaneous lymphoma and mastocytosis exhibit increased serum levels of IL-31 protein and elevated IL-31 mRNA in the skin. Interestingly, in some of these diseases, IL-31 serum levels correlate with disease activity. In the present review, we particularly focus on studies investigating IL-31 as a novel diagnostic biomarker indicating the severity of allergic diseases. We highlight a recent study on IL-31 in mastocytosis, which reports on elevated serum levels of IL-31 in adults correlating with the severity of disease categories, tryptase levels and percentage of bone marrow infiltration. We conclude that growing knowledge about IL-31, its receptors and signaling pathways serves to better understand the pathogenesis of allergic diseases and may lead to the development of novel treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510535     DOI: 10.1007/s11882-014-0423-y

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  53 in total

1.  Correlation of IL-31 serum levels with severity of atopic dermatitis.

Authors:  Ulrike Raap; Katja Wichmann; Manuela Bruder; Sonja Ständer; Bettina Wedi; Alexander Kapp; Thomas Werfel
Journal:  J Allergy Clin Immunol       Date:  2008-08       Impact factor: 10.793

2.  Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population.

Authors:  Cheng-Che E Lan; Hung-Pin Tu; Ching-Shuang Wu; Ying-Chin Ko; Hsin-Su Yu; Yi-Wei Lu; Wan-Chen Li; Yin-Chun Chen; Gwo-Shing Chen
Journal:  Exp Dermatol       Date:  2011-10-20       Impact factor: 3.960

Review 3.  Mast cell activation syndrome: a review.

Authors:  Marianne Frieri; Reenal Patel; Jocelyn Celestin
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

4.  Association of distinct IL-31 polymorphisms with pruritus and severity of atopic dermatitis.

Authors:  M Sokołowska-Wojdyło; J Gleń; M Zabłotna; K Rębała; M Sikorska; A Florek; M Trzeciak; W Barańska-Rybak; M Malek; B Nedoszytko
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-07-24       Impact factor: 6.166

5.  Functional effects of interleukin 31 in human primary keratinocytes.

Authors:  Sadaf Kasraie; M Niebuhr; K Baumert; T Werfel
Journal:  Allergy       Date:  2011-01-25       Impact factor: 13.146

6.  IL-31 regulates differentiation and filaggrin expression in human organotypic skin models.

Authors:  Christian Cornelissen; Yvonne Marquardt; Katharina Czaja; Jörg Wenzel; Jorge Frank; Juliane Lüscher-Firzlaff; Bernhard Lüscher; Jens M Baron
Journal:  J Allergy Clin Immunol       Date:  2011-12-15       Impact factor: 10.793

7.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

8.  A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema.

Authors:  Florian Schulz; Ingo Marenholz; Regina Fölster-Holst; Christiane Chen; Alexander Sternjak; Ria Baumgrass; Jorge Esparza-Gordillo; Christoph Grüber; Renate Nickel; Stefan Schreiber; Monika Stoll; Michael Kurek; Franz Rüschendorf; Norbert Hubner; Ulrich Wahn; Young-Ae Lee
Journal:  J Allergy Clin Immunol       Date:  2007-09-27       Impact factor: 10.793

9.  IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis.

Authors:  Song Kim; Hyun-Je Kim; Hee Seung Yang; Eugene Kim; Ik-Soo Huh; Jun-Mo Yang
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

10.  Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients.

Authors:  Joanna Narbutt; Irmina Olejniczak; Dorota Sobolewska-Sztychny; Anna Sysa-Jedrzejowska; Iwona Słowik-Kwiatkowska; Tomasz Hawro; Aleksandra Lesiak
Journal:  Arch Dermatol Res       Date:  2012-10-30       Impact factor: 3.017

View more
  24 in total

1.  Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression.

Authors:  Ramakrishna Edukulla; Brijendra Singh; Anil G Jegga; Vishwaraj Sontake; Stacey R Dillon; Satish K Madala
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

2.  Inhibition of natriuretic peptide receptor 1 reduces itch in mice.

Authors:  Hans Jürgen Solinski; Patricia Dranchak; Erin Oliphant; Xinglong Gu; Thomas W Earnest; John Braisted; James Inglese; Mark A Hoon
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

Review 3.  Tumor-Derived Exosomes and Their Role in Cancer Progression.

Authors:  Theresa L Whiteside
Journal:  Adv Clin Chem       Date:  2016-04-07       Impact factor: 5.394

Review 4.  [New treatment options for chronic pruritus].

Authors:  C Zeidler; B Pfleiderer; S Ständer
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751

5.  Feline Interleukin-31 Shares Overlapping Epitopes with the Oncostatin M Receptor and IL-31RA.

Authors:  Angelica V Medina-Cucurella; Gary F Bammert; William Dunkle; Christopher Javens; Yaqi Zhu; Veronica T Mutchler; Janet T Teel; Caitlin A Stein; Steve A Dunham; Timothy A Whitehead
Journal:  Biochemistry       Date:  2020-06-04       Impact factor: 3.162

6.  An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis.

Authors:  Amy S Paller; Yael Renert-Yuval; Maria Suprun; Hitokazu Esaki; Margeaux Oliva; Thy Nhat Huynh; Benjamin Ungar; Norma Kunjravia; Rivka Friedland; Xiangyu Peng; Xiuzhong Zheng; Yeriel D Estrada; James G Krueger; Keith A Choate; Mayte Suárez-Fariñas; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

Review 7.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors:  Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

8.  Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.

Authors:  Ying Zhang; Xiao-Ying Yao; Mei-Chun Gao; Jie Ding; Rong-Hua Hong; Hua Huang; Lei Zhuang; Yong-Gang Wang; Yong Hao; Yang-Tai Guan
Journal:  CNS Neurosci Ther       Date:  2017-11-06       Impact factor: 5.243

9.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Authors:  Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2016-01-13       Impact factor: 4.030

Review 10.  Targeting TRP ion channels for itch relief.

Authors:  Xuming Zhang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-25       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.